Biocon Limited, an innovation-led global biopharmaceutical company, today announced the signing of a licensing and supply agreement with Tabuk Pharmaceutical Manufacturing Company.
iOn a rolling basis, stocks which come in top 80% of total market-cap are considered largecaps, next 15% midcaps and remaining 5% smallcaps. (Total m-cap classification is done on a daily basis).